Medicare Cuts Cost of 10 Common Drugs Covered by Part D

被引：0
|
作者：
Anderer, Samantha
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 14期
关键词：
D O I：
10.1001/jama.2024.18192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Trends in Common Ownership among Insurers in Medicare Part D
    Chatterji, Pinka
    Ho, Chun-Yu
    Kamara, Alyssa
    Lee, Jaehak
    MEDICAL CARE, 2024, 62 (09) : 605 - 611
  • [22] Potential Savings in Medicare Part D for Common Urological Conditions
    Kirk, Peter S.
    Borza, Tudor
    Dupree, James M.
    Wei, John T.
    Ellimoottil, Chad
    Caram, Megan E. V.
    Burkhardt, Mary
    Heidelbaugh, Joel J.
    Hollenbeck, Brent K.
    Skolarus, Ted A.
    UROLOGY PRACTICE, 2018, 5 (05) : 351 - 358
  • [23] Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company
    Lalani, Hussain S.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 1053 - 1055
  • [24] Potential Cost Savings in Medicare Part D for Otolaryngologic Medications
    Om B. Tripathi
    Aman M. Patel
    Hassaam S. Choudhry
    David W. Wassef
    Paul T. Cowan
    Richard Chan Woo Park
    Andrey Filimonov
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2025, 77 (4) : 1969 - 1980
  • [25] Analysis of formulary coverage and cost of biologic disease modifying anti-rheumatic drugs in Medicare Part D
    Alghamdi, Ahmad
    Seoane-Vazquez, Enrique
    Rodriguez-Monguio, Rosa
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2018, 9 (03) : 199 - 206
  • [26] Cost savings from Medicare Part D plan comparisons
    O'Connell, Mary Beth
    Pelaccio, Karli
    Tabon, Patrick K.
    Rashid, Zenab
    Na, Sharon Y.
    Thomas, Hanadi
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (04) : 1275 - 1279
  • [27] IS MEDICARE PART D PLAN BENEFIT DESIGN ASSOCIATED WITH COST-RELATED NONADHERENCE TO PRESCRIPTION DRUGS? AN ANALYSIS USING THE MEDICARE CAHPS DATA
    Wei, I. I.
    Howell, B. L.
    Frankenfield, D. L.
    Anderson, K. K.
    Sekscenski, E.
    VALUE IN HEALTH, 2009, 12 (03) : A171 - A172
  • [28] High-Cost Drugs Account for Most of Medicare Part B Spending
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (06): : 572 - 572
  • [29] High-Cost, High-Value Oral Specialty Drugs: More Evidence on the Impact of Cost Sharing in Medicare Part D
    Huntington, Scott F.
    Davidoff, Amy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4307 - +
  • [30] 10 YEARS OF MEDICARE - IMPACT ON COVERED POPULATION
    GORNICK, M
    SOCIAL SECURITY BULLETIN, 1976, 39 (07) : 3 - 21
12345